Still, the allure of losing weight while eating bacon and burgers has persisted, and research suggests low-carb diets show promise for controlling blood-sugar levels, managing diabetes, and aiding weight loss
10.1021/acs.jafc.6b02509 J Agric Food Chem
21 (UPI) -- Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea
Current research attention centers on the mesolimbic dopamine system, which is involved in reward processing and is activated by substances such as alcohol, opioids, and stimulants
The safety and side effects of Saxenda, Wegovy, and Zepbound are largely the same, according to Fishman
Yeh AH, Jeffery PL, Duncan RP, Herington AC, Chopin LK